Terminalia arjuna Wight & Arn. (Combretaceae) is a tree having an extensive medicinal potential. The plant is used traditionally in the treatment of various aliments. T. arjuna is a very good hypocholsteremic, hypolipidemic, anticoagulant, antihypertensive, antithrombotic, antiviral, antifungal and antibacterial agent Various parts of plant have been investigated for the presence of phytoconstituents and pharmacological activities. Many useful phytoconstituents have been isolated from T. arjuna. Triterpenoids are mainly responsible for cardiovascular properties. Tannins and flavonoids are responsible for its anticancer properties. The present review summarizes the ethnic use, pharmacological activities of the extracts and phytoconstituents of T. arjuna for last 90 years.
Terminalia arjuna (Roxb.) Wight & Arn. is a herbal medicinal plant that is used in treatment of a large number of diseases, especially cardiac diseases along with common cardiovascular drugs like metoprolol, atorvastatin, enalapril maleate and aspirin. The aim of present study was to find out the safety of T. arjuna when co-administered with these drugs. Commercially available T. arjuna (Himalaya Herbal) was used for this studies. T. arjuna contains a number of active compounds that may have drug interaction. Based on parameters such as caking, liquefaction, odor, color and gel formation, no change was seen in the physical properties of T. arjuna alone and mixture of T. arjuna and cardiovascular drugs. The comparison of max values of individual drugs and their mixture with T. arjuna revealed that there is no interaction of T. arjuna with these cardiovascular drugs. T. arjuna can therefore be used safely along with these drugs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.